MannKind Corporation

Premium Company Profile

Publication Date	April 2008
Publisher	Datamonitor
Product Type	Report
Pages	46
ISBN Number	not applicable
Product Code	DAT11497

Price

£265.00
approximately: $521 | €337

PDF

PRINT £315 ($619 | €400)

Order above formats by FAX

Summary

Introduction

MannKind, a development-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic products for metabolical disorder and cancer. Technosphere Insulin (TI) System is the company's lead product candidate in Phase III development for treatment of type 1 and type 2 diabetes. The company is studying MKC1106 in Phase I trials for potential treatment of solid tumors.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

The company's insulin inhaler, Technosphere Insulin System is being studied in Phase III pivotal trails for diabetes in the US, Europe and Latin America. MKC1106, the company's potential cancer drug, is in Phase I trials for the treatment of solid tumors. MannKind recognized revenues of $0.1 million under a license agreement in 2006. The company did not record revenues between 2002 and 2005. The company is expected to generate revenues of $283.9 million during 2006-2010, as its lead product candidate TI System will contribute majority of revenue growth during the period in analysis.

Reasons to Purchase

Access all the important information and analysis on the company in a single report Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company's adjusted five year financial data along with key ratios and market capitalization .

Content

Overview
Catalyst
Summary
- Company Structure
- Company Overview and Key Facts
- Business Description
- History
- Company Financials
- Stock Market Performance
- P&l
- Balance Sheet
- Cash Flow
- Products & Services
- Pipeline Products
- Ac Forecast Product Sales
- Competitors and Strategic Business Relationships
- Key Competitors
- Key Suppliers
- Shareholding Structure
- Strategy
- Company View
- Corporate Strategy
- SWOT Analysis
- Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- Value Chain Analysis
- Overview
- Discovery and Product Development
- Manufacturing
- Scorecard
- Overview
- Scorecard Analysis
- Key Employees
- List of Key Employees
- Key Employee Biographies
- Financial and Operational Overview
- Financial and Operational Overview
Appendix
- Ask The Analyst
- Datamonitor Consulting
- Disclaimer
Table of Figures
- Figure 1: Mannkind- Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Figure 2: Mannkind- Key Strategic Products Revenues, 2006-2010 ($ Mn)
Table of Tables
- Table 1: Mannkind- Key Facts
- Table 2: Mannkind- Year-End Share Price and Market Capitalization, 2002-2006 ($)
- Table 3: Mannkind- Key Events Impacting Share Price Performance
- Table 4: Mannkind- Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 5: Mannkind- Operating Cost Ratio Analysis, 2002-2006 (% of Total Revenues)
- Table 6: Mannkind- Balance Sheet, 2002-2006 ($ Mn)
- Table 7: Mannkind- Cash Flow, 2002-2006 ($ Mn)
- Table 8: Mannkind- in-House Pipeline Products
- Table 9: Mannkind- Key Strategic Revenues, 2006-2010 ($ Mn)
- Table 10: Mannkind- Key Competitors
- Table 11: Mannkind- Key Suppliers
- Table 12: Mannkind- Key Shareholders
- Table 13: Mannkind- SWOT Analysis Summary
- Table 14: Mannkind- Value Chain Analysis
- Table 15: Mannkind- Scorecard
- Table 16: Mannkind- Key Employees
- Table 17: Mannkind- Financial and Operational Overview